Steven Cohen’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.22M Buy
286,323
+257,678
+900% +$3.43M ﹤0.01% 2098
2026
Q2
$418K Buy
+28,645
New +$379K ﹤0.01% 3252
2025
Q1
– Sell
-8,461
Closed -$186K – 2101
2024
Q4
$186K Sell
8,461
-89,785
-91% -$1.73M ﹤0.01% 1901
2024
Q3
$1.65M Buy
98,246
+39,946
+69% +$593K ﹤0.01% 1260
2024
Q2
$697K Sell
58,300
-30,200
-34% -$337K ﹤0.01% 1360
2024
Q1
$981K Buy
88,500
+83,200
+1,570% +$849K ﹤0.01% 1466
2023
Q4
$45.9K Buy
+5,300
New +$41.2K ﹤0.01% 2011

Other funds holding CLBT

Steven Cohen's CLBT Position: Q3 2026 in Review

Steven Cohen increased its Cellebrite (CLBT) stake by 900% in Q3 2026, buying an estimated $3.43M and bringing the position to 286,323 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Steven Cohen first reported a position in CLBT in Q4 2023 and has held it in 7 quarters since. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Steven Cohen held 286,323 shares of Cellebrite worth $3.22M as of Q3 2026.
  • Steven Cohen bought 257,678 Cellebrite shares in Q3 2026, an estimated $3.43M.
  • Cellebrite made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2098 holding.
  • Steven Cohen first reported a position in Cellebrite in Q4 2023 and has held it in 7 quarters since.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.